In a recent article published in the World Journal of Cardiology, scientists examined the therapeutic potential of mesenchymal stem cells (MSCs) to treat heart failure.
September, 12 2024
In a recent article published in the World Journal of Cardiology, scientists examined the therapeutic potential of mesenchymal stem cells (MSCs) to treat heart failure. The study focuses on the differences between bone marrow-derived MSCs (BM-MSCs) and umbilical cord-derived MSCs (UC-MSCs) and their ability to repair damaged heart tissue, reduce inflammation and improve heart function.
In a recent article published in the World Journal of Cardiology, scientists examined the therapeutic potential of mesenchymal stem cells (MSCs) to treat heart failure. The study focuses on the differences between bone marrow-derived MSCs (BM-MSCs) and umbilical cord-derived MSCs (UC-MSCs) and their ability to repair damaged heart tissue, reduce inflammation and improve heart function.
Latest news
Stem cells: restoring the liver according to science
January, 16 2025
Exosoms: helping blood vessels after treatment
January, 01 2025
Exosomes on the lookout for lung disease
November, 19 2024
Stem cells and exosomes against DIC syndrome
November, 16 2024
How do stem cells help fight kidney aging?
September, 21 2024